P240023/S005: WRAPSODY Cell-Impermeable Endoprosthesis
FDA’s recorded scope: a duplicate manufacturing line for the Wrapsody Cell-Impermeable Endoprosthesis
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 6 FDA records to the applicant name Merit Medical Systems, Inc.. The collection includes 4 510(k) clearances. 1 entry is a PMA supplement. 1 entry is a 30-day notice. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Dec 11, 2025 to Jul 27, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code PFV appears in 2 of the 6 linked filings. The collection spans 5 FDA product codes and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P240023, with 2 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: 1600 W. Merit Pkwy., South Jordan, UT, 84095, US. Recorded on K261310, decision dated Jul 27, 2026.
Dilator, Vessel, For Percutaneous Catheterization; Clamp, Vascular; System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment; Dressing, Wound, Drug; Probe, Radiofrequency Lesion.
FDA’s recorded scope: a duplicate manufacturing line for the Wrapsody Cell-Impermeable Endoprosthesis
FDA’s recorded scope: approval of the revised protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P240023
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
MedtechLedger links 27 FDA enforcement entries through the recorded recalling firm or an exact submission number published in FDA’s recall data. 5 Class I, 22 Class II records are represented. Each row is an enforcement entry; one recall event can cover several product entries. These counts describe this collection and do not measure a manufacturer’s safety record or an injury rate.
| Recall / product | Company | Classification | Report date | Source |
|---|---|---|---|---|
| Merit Medical Systems, Inc. | Class II | Oct 21, 2026 | FDA | |
| Merit Medical Systems, Inc. | Class II | Oct 7, 2026 | FDA | |
| Merit Medical Systems, Inc. | Class II | Jun 24, 2026 | FDA | |
| Merit Medical Systems, Inc. | Class II | May 6, 2026 | FDA | |
| Merit Medical Systems, Inc. | Class II | May 6, 2026 | FDA | |
| Merit Medical Systems, Inc. | Class II | May 6, 2026 | FDA |
Connections use the recorded recalling firm or the submission identifiers shown below. A shared submission connects the records; it does not establish that differently named legal applicants are interchangeable. Use the exact affected models, lots and instructions on each notice.
Search the firm’s recall recordsSource updated Nov 11, 2026. Retrieved Nov 19, 2026.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Merit Medical Systems, Inc. | 510(k) clearance | Jul 27, 2026 | FDA | |
| Merit Medical Systems, Inc. | 510(k) clearance | Jul 22, 2026 | FDA | |
WRAPSODY Cell-Impermeable EndoprosthesisP240023/S005 | Merit Medical Systems, Inc. | PMA supplement | Jun 11, 2026 | FDA |
StatSeal DiscK254073 | Merit Medical Systems, Inc. | 510(k) clearance | May 13, 2026 | FDA |
STAR RF Ablation SystemK251802 | Merit Medical Systems, Inc. | 510(k) clearance | Feb 13, 2026 | FDA |
WRAPSODY Cell-Impermeable EndoprosthesisP240023/S004 | Merit Medical Systems, Inc. | PMA supplement | Dec 11, 2025 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 20, 2026.